126 related articles for article (PubMed ID: 6177937)
1. Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure.
Pouleur H; Rousseau MF; van Mechelen H; Roncoroni L; Ries A; Charlier AA
J Cardiovasc Pharmacol; 1982; 4(3):409-18. PubMed ID: 6177937
[TBL] [Abstract][Full Text] [Related]
2. Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload.
Pouleur H; Marechal G; Balasim H; Van Mechelen H; Ries A; Rousseau MF; Charlier AA
J Cardiovasc Pharmacol; 1983; 5(5):861-7. PubMed ID: 6195477
[TBL] [Abstract][Full Text] [Related]
3. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
Hauf GF; Bubenheimer P; Roskamm H
Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic volume overload on left ventricular response to tachycardia.
Pouleur H; Rousseau MF; Petein M; Van Mechelen H; Charlier AA
Am J Physiol; 1983 Aug; 245(2):H218-28. PubMed ID: 6881356
[TBL] [Abstract][Full Text] [Related]
5. Neurally mediated cardiac effects of forskolin in conscious dogs.
Iwase M; Ishikawa Y; Shen YT; Shannon RP; Sato N; Ganguly PK; Eki T; Vatner DF; Vatner SF
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1473-82. PubMed ID: 8897942
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the cardiotonic effects of AR-L115 and AR-L57: evidence for distinct inotropic mechanisms.
Hayes JS; Wyss VL; Wilson H; Pollock GD
J Cardiovasc Pharmacol; 1985; 7(1):182-9. PubMed ID: 2580141
[TBL] [Abstract][Full Text] [Related]
7. Effects of AR-L 115 on contraction and relaxation of isolated mammalian cardiac muscle.
Brutsaert DL; De Clerck NM; Housmans PR; Van Ocken ER
J Cardiovasc Pharmacol; 1982; 4(3):333-43. PubMed ID: 6177927
[TBL] [Abstract][Full Text] [Related]
8. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
9. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
12. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs.
Tanio H; Kumada T; Hayashi M; Himura Y; Nakamura Y; Kawai C
Jpn Circ J; 1991 Nov; 55(11):1068-76. PubMed ID: 1749068
[TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
[TBL] [Abstract][Full Text] [Related]
15. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
16. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the cardiovascular and biochemical actions of the imidazo [4,5b] pyridine sulmazole and an imidazo [4,5c] pyridine analogue, BW A746C.
Allan G; Cambridge D; Follenfant MJ; Stone D; Whiting MV
Br J Pharmacol; 1988 Feb; 93(2):387-98. PubMed ID: 3359112
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
Greenberg S; Touhey B
J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Udvary E; Papp JG; Végh A
Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure.
Adachi H; Tanaka H
J Cardiovasc Pharmacol; 1997 Jun; 29(6):763-71. PubMed ID: 9234657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]